LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 389 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $348,000 | -13.0% | 3,500 | 0.0% | 0.01% | -7.7% |
| Q2 2019 | $400,000 | +0.5% | 3,500 | +10.6% | 0.01% | -7.1% |
| Q1 2019 | $398,000 | -7.2% | 3,164 | 0.0% | 0.01% | -17.6% |
| Q4 2018 | $429,000 | -50.6% | 3,164 | 0.0% | 0.02% | -41.4% |
| Q3 2018 | $869,000 | +36.2% | 3,164 | +2.7% | 0.03% | +31.8% |
| Q2 2018 | $638,000 | +25.3% | 3,080 | 0.0% | 0.02% | +22.2% |
| Q1 2018 | $509,000 | +20.6% | 3,080 | 0.0% | 0.02% | +20.0% |
| Q4 2017 | $422,000 | +28.7% | 3,080 | +27.9% | 0.02% | +25.0% |
| Q3 2017 | $328,000 | +39.6% | 2,408 | +24.6% | 0.01% | +33.3% |
| Q2 2017 | $235,000 | +113.6% | 1,932 | +86.5% | 0.01% | +125.0% |
| Q1 2017 | $110,000 | +29.4% | 1,036 | +23.3% | 0.00% | 0.0% |
| Q4 2016 | $85,000 | – | 840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,199,766 | $130,078,630,000 | 35.65% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 852,053 | $92,380,000 | 5.34% |
| OBERWEIS ASSET MANAGEMENT INC/ | 101,127 | $10,964,000 | 3.08% |
| Timpani Capital Management LLC | 68,160 | $7,390,000 | 3.00% |
| ASHFORD CAPITAL MANAGEMENT INC | 103,420 | $11,213,000 | 2.64% |
| First Light Asset Management, LLC | 56,818 | $6,160,000 | 2.58% |
| Conestoga Capital Advisors, LLC | 286,162 | $31,026,000 | 2.51% |
| OAK RIDGE INVESTMENTS LLC | 955,599 | $103,606,000 | 2.48% |
| RK Capital | 127,983 | $13,876,000 | 2.42% |
| Nichols Asset Management LLC | 93,170 | $10,101,000 | 2.20% |